Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oncologic Drugs Advisory Committee meets next week

Dec. 10, 1997

Preclinical toxicity profile of ISIS-2503

Dec. 9, 1997

SunPharm's anticancer drug completes phase I

Dec. 8, 1997

IntraBiotics signs manufacturing and supply agreement for IB-367

Dec. 8, 1997

Zeneca selects EGFR-TK inhibitor for clinical evaluation

Dec. 8, 1997

Oncaspar approved in Canada

Dec. 5, 1997

Sugen initiates phase II prostate cancer trial with SU-101

Dec. 5, 1997

Genta to evaluate G-3139 in U.S. prostate cancer trial

Dec. 5, 1997

Fareston launched in U.S. for metastatic breast cancer

Dec. 4, 1997

Agouron, Roche terminate cancer collaboration; AG-337 development discontinued

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026